Anebulo Pharmaceuticals, Inc. (ANEB) Return On Assets % [USD] 2021 - 2024

Historical data

Taxonomy & unit
ratio: %
Description
Return on assets can be defined as an indicator of how profitable a company is relative to its total assets. Calculated by dividing a company's operating earnings by its total assets.
Summary
Anebulo Pharmaceuticals, Inc. quarterly/annual Return On Assets history and growth rate from 2021 to 2024.
  • Anebulo Pharmaceuticals, Inc. Return On Assets for the quarter ending March 31, 2024 was -109 %, a 57.7% decline year-over-year.
  • Anebulo Pharmaceuticals, Inc. annual Return On Assets for 2023 was -74.7 %, a 97.8% decline from 2022.
Return On Assets, Quarterly (% [USD])
Return On Assets, YoY Quarterly Growth (%)
Period Value YoY Chg Change % Start Date End Date
Q1 2024 -109 -40 -57.7% Jan 1, 2024 Mar 31, 2024
Q4 2023 -98.4 -37.2 -60.8% Oct 1, 2023 Dec 31, 2023
Q3 2023 -89.2 -45.1 -102% Jul 1, 2023 Sep 30, 2023
Q2 2023 -74.7 -37 -97.8% Apr 1, 2023 Jun 30, 2023
Q1 2023 -69.3 +102 +59.6% Jan 1, 2023 Mar 31, 2023
Q4 2022 -61.2 +136 +69% Oct 1, 2022 Dec 31, 2022
Q3 2022 -44 Jul 1, 2022 Sep 30, 2022
Q2 2022 -37.8 Apr 1, 2022 Jun 30, 2022
Q1 2022 -172 Jan 1, 2022 Mar 31, 2022
Q4 2021 -197 Oct 1, 2021 Dec 31, 2021
* An asterisk sign (*) next to the value indicates that the value is likely invalid.